CII modified peptide (Peking University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameCII modified peptide (Peking University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionT-cell receptor inhibitors
TargetsT-cell receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesPeking University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPeking University
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A